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Alcohol use disorders are themost commonmental disorder world-
wide with an estimated 3.6% prevalence among adults aged 15–65
(Rehm et al., 2009). They are associated with signiﬁcant morbidity as
well as negative social consequences for both the sufferer and those
around them.
The categorization of alcohol use disorders is complicated and the
subject of much debate. Within the current World Health Organisa-
tion International Classiﬁcation of Disease (ICD 10) alcohol depen-
dence syndrome is a separate diagnosis characterised by a cluster
of behavioural, cognitive and physiological phenomena including a
strong desire to drink alcohol, difﬁculty in controlling use, tolerance
(need to consume greater amounts to get the same effect) and with-
drawal symptoms on stopping alcohol use distinct from the diagno-
sis “harmful alcohol use” (World Health Organisation, 1997). Until
recently this distinction was also reﬂected in the American Psychiat-
ric Association Diagnostic and Statistical Manual of Mental Disorders
(DSM IV) but within the DSM V updated in 2013 the previous diag-
noses of “alcohol dependence” and “alcohol abuse” were merged to
one diagnosis of “Alcohol Use Disorder” due to concern that these
are not two distinct phenomena but represent a spectrum of severity
of the same underlying disorder (National Institute on Alcohol Abuse
and Alcoholism, 2015).
In their systematic literature review and meta-analysis Laramée and
colleagues have shown that those with alcohol dependence (using
broad criteria not limited to clinical diagnoses by either ICD 10 or DSM
IV criteria) are at approximately 3.5 times higher risk of death than the
general population (Laramée et al., 2015). This ﬁnding is similar to a pre-
vious systematic review of the association between all alcohol use disor-
ders and mortality which found that mortality risk was 3 times higher
in men and over 4 times higher in women with alcohol use disorders
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(Roerecke and Rehm, 2013). Interestingly however Laramée et al. also
showed an increase inmortality of 25% among those with alcohol depen-
dence compared to thosewith criteria for the diagnosis alcohol abuse sug-
gesting an increased severity of this diagnosis in terms of health risk, even
if the two conditions represent an underlying continuum. Roerecke and
Rehm have previously shown that this increased risk in those with alco-
hol use disorders is found for all causes of death with particularly high
standardised mortality ratios for digestive disease, especially liver cirrho-
sis, andmental disorders (Roerecke and Rehm, 2014). Risk fromuninten-
tional injuries and suicides was also substantially higher. Cause-speciﬁc
mortality from alcohol dependence has not been investigated in this
way but similarities between ﬁndings for both alcohol use disorders and
alcohol dependence and all-cause mortality suggest that this pattern is
likely to be similar.
In addition to showing the substantial increasedmortality risk found
in those with alcohol dependence Laramée et al. also consider whether
mortality risk differed among those with alcohol dependence who con-
tinue to drink heavily versus those who are abstinent and those who
have reduced their alcohol consumption. The results show a dose–
response with lowest mortality in those who are abstinent but also re-
duced mortality in those who reduce their drinking. The authors use
this ﬁnding to justify reducing drinking as a valid treatment outcome
alongside total abstinence, but further than this these results add to
body of evidence that effective treatment outcome which actually
leads to decreases in drinking can save lives. If reducing alcohol con-
sumption even among those in treatment, who are likely to have the
most severe disease, results in lower mortality then it is clear that the
health effects of heavy alcohol use are at least to some extent reversible
and it is never too late to intervene. The ﬁndings from Laramée et al. are
consistent with ﬁndings for alcohol use disorder that decreasing alcohol
consumption substantially reduces the increased mortality risk associ-
ated with this illness (Roerecke et al., 2013). However despite the
high prevalence of alcohol use disorders and the high cost associated
with morbidity and mortality the treatment gap for alcohol use disor-
ders is larger than for any other mental disorder (Kohn et al., 2004).
The majority of people with alcohol use disorders receive no treatment
at all (Kohn et al., 2004; Drummond et al., 2011).
Reasons for this low level of treatment are multi-factorial and di-
verse but stigma (Schomerus et al., 2011), lack of recognition by medi-
cal professionals and low levels of funding (Kohn et al., 2004) are likely
to be key factors. The paper from Laramée et al. showing the substantial
increased mortality among those with alcohol dependence emphasises
the need for both better prevention and treatment of this harmful
disease.
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